Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Mark A. Cline, of Cline Realtor Group, Embarks on a Journey to Transform Lives with Asea Redox
Asea Redox is a pioneering company that specializes in cellular health and wellness products. By harnessing the power of redox signaling molecules, Asea Redox offers innovative solutions that support optimal cellular communication and regeneration, ultimately leading to improved overall well-being. - September 28, 2023 - Cline Realtor Group
Hemanext Inc. Announces Significant Milestone with FDA Marketing Authorization for Hemanext ONE®, Hemanext’s Innovative Red Blood Cell (RBC) Processing and Storage System
Hemanext ONE has been granted marketing authorization for commercial distribution via the De Novo process by the U.S. Food and Drug Administration (FDA). - September 21, 2023 - Hemanext
NeVa CLEAR Study Results Presented at ESMINT: Innovative Thrombectomy Device Achieves Notable First-Pass Success and Patient Outcomes
Primary results from the CLEAR Study(1) were presented at the ESMINT annual meeting in Marseille, France (4-6 September 2023), where Vesalio also announced the fifth anniversary of the international commercialization of the NeVa™ device. - September 21, 2023 - Vesalio
Alevea Mental Health Advocates for Psychedelic Therapy, Citing MAPS' Latest Research and Its Own Success with Ketamine Treatment
Alevea Mental Health fully endorses psychedelic therapy as an effective mental health treatment, following the recent publication of MAPS' Phase 3 study on MDMA-assisted therapy for PTSD. Alevea has already reported significant success in alleviating symptoms of anxiety, depression, and PTSD through its own Ketamine treatment programs. CEO Topher Bradshaw expressed astonishment at the remarkable patient improvements, particularly when other treatments had failed. - September 20, 2023 - Alevea Mental Health
DEA and Telemedicine: East Coast Telepsychiatry's Push for Modernized Rules
On September 12 and 13, 2023, the DEA discussed telemedicine regulations. East Coast Telepsychiatry's representatives, Pierre Montalvo and Dan Golden, attended in Arlington, VA. Mr. Golden emphasized the importance of telemedicine in prescribing controlled substances. The 2008 Ryan Haight Act's regulations are outdated, prompting the DEA to reconsider after receiving a record of over 38,000 complaints. - September 18, 2023 - East Coast Telepsychiatry
National Brain Tumor Society to Launch Campaigns Elevating the Necessity of Clinical Trials and Biomarker Testing Access, Guiding More Informed Treatment Decisions
Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care. - September 13, 2023 - National Brain Tumor Society
MPFI’s Wang Lab Awarded $1M Grant to Study Mechanism Behind Memory Decline in Alzheimer’s
Memory loss is one of the most devastating effects of Alzheimer's disease, yet the mechanisms behind it remain a mystery. MPFI is working to change that through a new $1,038,819 research award from the National Institute on Aging of the NIH. - August 23, 2023 - Max Planck Florida Institute for Neuroscience
Renowned Stem Cell Expert Dr. Roddy McGee Joins Forces with GARM Clinic for Groundbreaking Collaboration in Regenerative Medicine
Leading the charge in regenerative medicine innovation, GARM Clinic is proud to announce a strategic partnership with the acclaimed Dr. Roddy McGee, widely recognized for his expertise in orthopedic surgery, stem cell therapeutics, the high-level care he provides to elite athletes, and his... - August 23, 2023 - GARM Clinic
Huntington Study Group Welcomes FDA Approval of New Drug for Chorea in Huntington’s Disease
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in clinical trials for Huntington’s disease (HD), today shares that the Phase 3 pivotal KINECT®-HD study conducted by HSG in collaboration with Neurocrine Biosciences,... - August 18, 2023 - Huntington Study Group
EndoGlow Revolutionizes Fluorescence-Guided Minimally Invasive Surgery with the GreenEgg™ Fluorescent Manipulator
EndoGlow, a pioneering medical technology company, proudly announces the launch of its breakthrough product, the GreenEgg™ fluorescent manipulator. Designed to revolutionize fluorescence-guided minimally invasive surgeries, the GreenEgg™ brings a new level of capability and innovation... - August 16, 2023 - EndoGlow
Huntington Study Group Announces Positive Topline Results for Virtual Unified Huntington’s Disease Rating Scale® (vUHDRS®) Study
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), today announces positive topline results from its Virtual Unified Huntington’s Disease Rating Scale®... - August 14, 2023 - Huntington Study Group
Neurobit Launches Neurobit HUB: A Comprehensive Tool for Streamlining Sleep and Population Health Research
Neurobit announces the launch of Neurobit HUB, a groundbreaking AI-driven tool for sleep and population health research. Integrating 40 sleep biomarkers, 20 health AI modules, and clinically validated devices, it's designed to streamline clinical trials, foster collaboration, and accelerate discoveries. A revolutionary step in sleep science. Learn more at https://www.neurobit.com/research/hub - August 14, 2023 - neurobit
The ALS Therapy Development Institute and Unite Genomics Partner to Integrate Electronic Health Records Into the ALS Research Collaborative
The ALS Therapy Development Institute (ALS TDI) is partnering with Unite Genomics, a leading healthcare data analytics company, to integrate electronic health record (EHR) data into the ALS Research Collaborative (ARC) via Unite Genomics’ state-of-the-art healthcare data access and analytics... - August 02, 2023 - ALS Therapy Development Institute
Emmanuel J. Ajala Chosen as a Lifetime Featured Member by Strathmore’s Who’s Who Worldwide
Emmanuel J. Ajala of Bronx, New York, has been chosen as a Lifetime Featured Member by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of research. About Emmanuel J. Ajala Emmanuel J. Ajala is a biomedical researcher/principal... - July 26, 2023 - Strathmore Worldwide
Huntington Study Group and CHDI Foundation Collaborate on Enroll-HD
HSG Clinical Research, Inc. - the Huntington Study Group’s clinical research organization (CRO) and wholly owned subsidiary (collectively referred to here as HSG) - has begun providing CRO services for CHDI Foundation’s Enroll-HD observational study and clinical research platform in the... - July 25, 2023 - Huntington Study Group
Shark Tank's Kevin Harrington Joins Forces with GARM Clinic
GARM Clinic, a leading provider of Stem Cell Therapies and cutting-edge Regenerative Therapies, is thrilled to announce a groundbreaking partnership with Kevin Harrington, renowned entrepreneur and original "shark" from the hit TV series "Shark Tank." This collaboration marks a... - July 20, 2023 - GARM Clinic
Singapore MedTech Startup Launches Strategic Research Collaboration with Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System
NDR Medical Technology Pioneers Automated Needle Targeting Technology: Strategic Research Collaboration initiated with Clinicians from Stanford University School of Medicine and the Veterans Affairs Palo Alto Health Care System - July 17, 2023 - NDR Medical Technology
NDR Medical Technology’s ANT-X Granted FDA Clearance, Paving the Way for Image-Guided Surgeries
ANT-X is an interventional robot that leverages C-arm fluoroscopy to help clinicians achieve swift and accurate percutaneous needle placement. NDR Medical Technology, an AI-empowered interventional robotics company, today announced that the ANT-X has been granted FDA 510(k) clearance by the U.S. - July 17, 2023 - NDR Medical Technology
Paras Biopharma (Biologics CDMO) Announces Industry Leading Scale-up Development & Production Process of an “Onco-Immunology Fc-fusion Biologic”
Paras Biopharma (Biologics CDMO) Finland team is pleased to announce that its extensive efforts have resulted in the successful scale-up, optimization & development of a biologically-active onco-immunology, “peptide FC-fusion” biologic. - July 12, 2023 - Paras Biopharmaceuticals Finland Oy
Hemanext Announces Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, today announced its membership in the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the region's premier trade association for small to medium-sized companies in the pharmaceutical,... - July 05, 2023 - Hemanext
UserWise, LLC Celebrates Role in Norlase Obtaining 510(k) Clearance and CE Mark Approval
UserWise, LLC, a San Jose-based human factors consultancy, is pleased to announce its instrumental role in obtaining FDA 510(k) clearance and CE Mark approval for the Norlase ECHO™ Green Pattern Laser photocoagulator. UserWise began working with Norlase in 2018 to develop and execute the... - June 23, 2023 - UserWise, LLC
ALPCO Receives FDA 510(k) Clearance for the Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay. The Calprotectin Immunoturbidimetric (IT) Assay is now IVDD and 510(k)-cleared for in... - June 15, 2023 - ALPCO
ClinicalPURSUIT is Currently Offering a Free Demonstration of Their State-of-the-Art Clinical EDC System
The Missouri-based EDC systems provider is helping clinicians, data managers, and CROs with seamless data capturing through their world-class software and solutions and free demos. - June 13, 2023 - ClinicalPURSUIT
Hemanext Announces a Strategic Partnership and Investment from Vitalant
Partnership to include research and development at Vitalant Innovation Center. - June 07, 2023 - Hemanext
Opening New Frontiers in Oral Care and the Cannabinoid Market
A groundbreaking patent has been unveiled, presenting a revolutionary method for the prevention and treatment of dental pulp-associated diseases using a cannabinoid-based composition. This patent offers pharmaceutical companies a unique opportunity to enter the rapidly growing cannabinoid market while addressing critical dental care needs. - June 04, 2023 - CannIBite
Sonar Clinical Research Diversity in Clinical Trials Summit Signifies a Significant Achievement in Promoting Healthcare Equity Within the Community
The Diversity in Clinical Trials Summit, held on April 22nd 2023, at The Gathering Spot, Atlanta Ga proved to be an extraordinary community event focused on promoting diversity and inclusion within the field of clinical research. The summit brought together renowned experts, thought leaders,... - June 04, 2023 - Sonar Clinical Research
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those impacted by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease... - June 01, 2023 - Huntington Study Group
TwitchView® Train of Four Monitor Used to Eliminate Residual Neuromuscular Blockade
ASA guideline first author Dr. Stephan Thilen et al. reports exciting results from a protocol that completely eliminated post-operative residual neuromuscular blockade (PRNMB). Of note, Thilen et al. achieved this groundbreaking advance in patient safety using the TwitchView® Train of Four (TOF) monitor while maintaining a role for neostigmine as a reversal strategy, resulting in pharmacologic cost savings of $42 per patient. - May 30, 2023 - Blink Device Company
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group
GARM Clinic Introduces GARM Community: a Patient-Centric Initiative to Foster Healthier Living and Stronger Connections
The GARM Clinic, a pioneer in regenerative medicine, proudly announces the launch of the GARM Community, a groundbreaking initiative designed to enhance patient care, create a sense of belonging, and promote healthier living for past, present, and future patients. This innovative program aims to... - May 19, 2023 - GARM Clinic
Huntington Study Group Achieves Last Patient Last Visit for Its Observational Study to Test Virtual Use of the Unified Huntington’s Disease Rating Scale®
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., announces an important milestone in the novel observational study Virtual Unified Huntington’s Disease Rating Scale (vUHDRS™). The last participant completed the last visit, marking... - May 16, 2023 - Huntington Study Group
MPFI Researcher Receives Prominent Award to Launch New Lab
The Max Planck Florida Institute for Neuroscience announces that Dr. Madineh Sarvestani has been named a Freeman Hrabowski Scholar by the Howard Hughes Medical Institute. The award provides up to $8.6 million for five to 10 years to support outstanding early-career faculty members who have strong potential to become leaders in the field and who are committed to advancing diversity, equity, and inclusion in science through their mentorship of trainees from populations underrepresented in science. - May 09, 2023 - Max Planck Florida Institute for Neuroscience
Northern College and the Canadian College of Naturopathic Medicine Announce Collaboration
Memorandum of Understanding underscores current need to increase access for health care learners and develop health care resources in northern communities - May 03, 2023 - Canadian College of Naturopathic Medicine
NanoCellect Biomedical Announces New Distribution Partnerships in Asia and Europe
NanoCellect Biomedical, the leading provider of microfluidic flow cytometry platforms, has announced new distributor partnerships in Asia and Europe to expand its global reach and provide greater accessibility to its innovative technologies. - April 26, 2023 - NanoCellect Biomedical
Thermo Fisher Partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
ALPCO-GeneProof, a global leader in diagnostics, and Thermo Fisher announced a strategic partnership that brings the TaqPath Menu | GeneProof PCR kits to market. The partnership combines the strengths of ALPCO-GeneProof’s expertise in molecular diagnostics with Thermo Fisher’s robust... - April 17, 2023 - ALPCO
Black Students in Pittsburgh 3-D Print Living Artery as Part of C-3PO Project
In the C-3PO project of The Citizen Science Lab, African American high school and middle school students have 3-D printed their first living body part. - April 12, 2023 - The Citizen Science Lab
Trent University and Canadian College of Naturopathic Medicine Partner to Create New Pathways to Careers in Holistic Healthcare
Memorandum of Understanding Establishes Partnership for Innovative Research and Program Collaboration - April 11, 2023 - Canadian College of Naturopathic Medicine
HSG and HD-CAB Collaborate to Provide Global Patient Advisory Board
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), recently collaborated with Huntington’s Disease – Community Advisory Board (HD-CAB) to provide a... - March 30, 2023 - Huntington Study Group
New Research on Decentralized Clinical Trial (DCT) Strategies to Boost Patient Diversity
Current and Future Clinical Trial Participants Link Enhanced Diversity and Inclusion of Underrepresented Patient Populations to DCT - March 29, 2023 - Life Science Strategy Group, LLC
World Class Hospitals Join DNA Damage Response Consortium to Bring Forward New Treatments for Adults and Children with Brain Cancer
Researchers from St. Jude Children’s Research Hospital, NYU, UCSF, and the University of Minnesota join National Brain Tumor Society and Yale-led Initiative - March 29, 2023 - National Brain Tumor Society
Emmanuel J. Ajala Honored as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide
Emmanuel J. Ajala, of Bronx, New York, has been recognized as a Professional of the Year for 2023 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of research. About Emmanuel J. Ajala Emmanuel J. Ajala is a biomedical... - March 29, 2023 - Strathmore Worldwide
HSG Announces 30th Annual Meeting
The Huntington Study Group (HSG), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently announced that their 2023 Annual Meeting will be held November 2-4, 2023 at the Sheraton Grand at Wild Horse Pass in Chandler, AZ, a... - March 21, 2023 - Huntington Study Group
Diversity in Clinical Trials Summit 2023
Upcoming Diversity in Clinical Trials Summit Aims to Address Disparities and Improve Patient Outcomes. - March 20, 2023 - Sonar Clinical Research
Breaking Barriers: ALS TDI Unveils Groundbreaking ALS Research Collaborative (ARC) to Accelerate Global Research in ALS
The ALS Research Collaborative will revolutionize ALS research by providing scientists with unprecedented access to the data and tools they need to discover new treatments and accelerate progress toward cures for ALS. - March 15, 2023 - ALS Therapy Development Institute
Disability Advocates Announce Endorsement of the All of Us Research Program
The American Association on Health and Disability announces the release of “No Research About Us Without Us," a statement endorsing the National Institutes of Health’s All of Us Research Program, an effort to engage more than one million people from across the United States in biomedical research to advance health care for all. - March 15, 2023 - American Association on Health and Disability
New Research Identifies Latest Clinical Development and CRO Outsourcing Trends in China
Groundbreaking Research Explores the Chinese Innovative Biopharmaceutical Clinical Development Market, CRO Outsourcing and Future Growth with Over 100 Chinese Biopharma Professionals - March 15, 2023 - Life Science Strategy Group, LLC
Creative Biolabs Looks Forward to a Year of Prosperity for Exosome Studies
Creative Biolabs expressed hopes that further progress could be made in the field of exosome research. - March 08, 2023 - Creative Biolabs
NeuroSolution Center of Austin Introduces Innovative Laser Activated PRP Procedure for Restorative Medicine
The NeuroSolution Center of Austin has announced a revolutionary treatment, the Laser Activated Platelet Rich Plasma (PRP) procedure. Developed with the expertise of renowned neurosurgeon Dr. Marcella Madera, the procedure harnesses the regenerative power of PRP, enhanced by laser activation. Suitable for a range of conditions, it offers a natural alternative to traditional medical interventions, and future rounds of the procedure are scheduled for interested individuals. - February 26, 2023 - Neurosolution
Memorial Healthcare Institute for Neuroscience Raises the Bar for Patient-Centered Care with AwareNow Health Streams
In partnership with Awareness Ties, Memorial Healthcare Institute for Neuroscience is pioneering a new level in patient-centered care. With AwareNow Health Streams, the Institute for Neuroscience at Memorial Healthcare is closing the gap between the patient and the provider while setting a new standard in care. - February 20, 2023 - Awareness Ties